## MO: Altria Group, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -2.2% below STRENGTH zone (3.0-6.0%); PEG 4.01 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($56.50)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?**
- Source: TradingView | 20251202T170633 | Somewhat-Bullish | Relevance: 100%
- Altria (MO) achieved a 3.6% growth in adjusted earnings per share (EPS) in Q3 2025, despite a 1.7% decline in revenues, driven by margin expansion in smokeable and oral tobacco segments, and share repurchases. The company's EPS growth was primarily shaped by profitability and capital return dynamics rather than top-line expansion, contrasting with peers like Philip Morris International and Turning Point Brands who saw both revenue and EPS growth. Altria's shares have gained 4.4% in the past month and trade at a lower forward P/E ratio compared to its industry, with analysts holding a Zacks Rank #3 (Hold) on the stock.

**2. Can Altria Sustain EPS Gains as Revenues Decrease 1.7% Y/Y?**
- Source: Yahoo Finance Singapore | 20251202T071400 | Somewhat-Bullish | Relevance: 100%
- Altria Group, Inc. reported a 3.6% growth in adjusted EPS to $1.45 in Q3 2025, despite a 1.7% year-over-year revenue decline. This growth was attributed to higher adjusted operating companies income, driven by pricing gains and margin expansion in both smokeable and oral tobacco segments, and a reduced share count due to buybacks. The article also compares Altria's performance to peers like Philip Morris International and Turning Point Brands, which achieved both EPS and revenue growth.

**3. Invesco Ltd. Sells 194,205 Shares of Altria Group, Inc. $MO**
- Source: MarketBeat | 20251204T120835 | Neutral | Relevance: 100%
- Invesco Ltd. reduced its holdings in Altria Group, Inc. by 1.6% in the second quarter, selling 194,205 shares and retaining approximately 0.72% of the company worth $706 million. Despite this, other institutional investors have recently increased their stakes in Altria. The company also announced a $2.00 billion stock repurchase program and reported Q3 earnings of $1.45 EPS, beating consensus estimates.

**4. M&T Bank Corp Reduces Holdings in Altria Group, Inc. $MO**
- Source: MarketBeat | 20251204T120729 | Somewhat-Bullish | Relevance: 100%
- M&T Bank Corp decreased its holdings in Altria Group, Inc. by 6.0% in the second quarter, selling 34,017 shares to hold 532,769 shares valued at $31.236 million. Altria's Board authorized a $2.00 billion stock buyback, indicating management believes the stock is undervalued. Analysts currently have a consensus "Hold" rating for Altria with an average price target of $62.33, while the stock trades near $58.83.

**5. Altria Group, Inc. $MO Shares Sold by Panagora Asset Management Inc.**
- Source: MarketBeat | 20251204T120029 | Neutral | Relevance: 100%
- Panagora Asset Management Inc. reduced its stake in Altria Group, Inc. (NYSE:MO) by 35.8% in the second quarter, selling 31,685 shares. Despite this, other institutional investors increased their holdings, and 57.41% of the stock is currently owned by hedge funds and institutional investors. Altria Group recently announced a $2.00 billion stock repurchase plan, indicating its board believes the stock is undervalued.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (-0.4%)
- Blackrock Inc.: 7.5% (+2.4%)
- State Street Corpora: 4.3% (-0.9%)
- Charles Schwab Inves: 3.5% (-4.7%)
- Geode Capital Manage: 2.7% (+1.2%)

### Key Risks

1. Valuation stretched: PEG 4.0x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.01 signals overvaluation risk, limited margin of safety. Forward P/E 10.4x stretched relative to 3% growth. Quality metrics strong (ROA 22%, margin 44%). Balance sheet: $3.0B free cash flow. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $96.8B |
| Beta | 0.50 |
| 52W Range | $50.08 - $68.60 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.01 |
| Forward P/E | 10.4 |
| Current P/E | 10.7 |
| YoY Growth | 2.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 weakening modestly (-0.6% over 5 days). Below STRENGTH zone by 5.2pp (needs >3.0% for momentum thesis). Below SMA200 (0.96x), long-term trend not supportive. RSI neutral at 43. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.16% (CS: 30) | Weak |
| RSI_14 | 42.6 | Neutral |
| MACD Histogram | 0.28 | Bullish |
| vs SMA20 | 1.001x | Above |
| vs SMA50 | 0.948x | Below |
| vs SMA200 | 0.963x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $58.34
- **Stop Loss:** $56.50 (3.2% risk)
- **Target:** $60.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 271
- **Position Value:** $15,810.14
- **Portfolio %:** 15.81%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-29 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.45 | $1.45 | +0.1% |
| 2025Q2 | $1.38 | $1.44 | +4.0% |
| 2025Q1 | $1.19 | $1.23 | +3.5% |
| 2024Q4 | $1.28 | $1.29 | +0.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*